AI partnerships and sports tie up put the focus on Accenture stock

Accenture (ACN) is back on investors’ radar after a wave of AI focused partnerships and investments, capped by a new multi year role modernizing the Women’s Tennis Association’s digital infrastructure.

Despite a 3.22% 1 day share price return lifting Accenture to US$180.19, the 30 day share price return of 8.67% and year to date share price return of 30.68% point to fading momentum alongside a 1 year total shareholder return of 40.14% and a 5 year total shareholder return of 31.18%, even as Accenture highlights new AI focused deals with the WTA, ServiceNow, Google Cloud and others.

If you are tracking how AI focused service providers are priced, it can be helpful to see what else the market is rewarding through our screener of 40 AI infrastructure stocks

So with Accenture trading at US$180.19, sitting on a 30 day share price return of 8.67% and an indicated intrinsic discount of 45.50%, is there still value on the table, or is the market already pricing in future growth?

Most Popular Narrative: 47.6% Undervalued

According to WallStreetWontons, the most followed narrative sees Accenture’s fair value at $343.90, well above the last close at $180.19, and builds that view on specific assumptions about growth, margins and future earnings multiples.

Catalysts
Products or Services that Could Move Sales or Earnings Meaningfully

• Generative AI (GenAI): Accenture reported $3 billion in new GenAI bookings in FY'24, including $1 billion in Q4. GenAI revenue was nearly $900 million for the full year, up significantly from FY'23.

Curious what justifies a fair value that far above today’s price? This narrative leans on steady top line expansion, improving profitability and a richer future earnings multiple. The full story connects those moving parts into one valuation blueprint.

Result: Fair Value of $343.90 (UNDERVALUED)

However, this depends on clients actually ramping up GenAI and cloud projects, and on enterprise spending cuts or sector specific revenue softness not lasting longer than expected.

Another View: What The P/E Ratio Suggests

While the user narrative leans on a rich future earnings multiple and a fair value of $343.90, the current picture is more mixed. Accenture trades on a 14.5x P/E, which is in line with peers at 14.5x, below the US IT industry at 21.4x, and below a fair ratio of 30.1x that the market could move towards. That combination hints at both valuation support and real re rating risk if growth disappoints. How much weight do you put on each side of that trade off?

Next Steps

With sentiment leaning cautiously optimistic, do not wait for others to decide the story for you. Instead, review the company’s potential rewards through the 4 key rewards

Looking for more investment ideas?

If you only focus on one stock, you might miss opportunities sitting in plain sight, so use targeted screens to quickly surface ideas that match your style.

• Target potential future standouts before the crowd notices by scanning a screener containing 23 high quality undiscovered gems built around quality fundamentals and solid financials.
• Prioritize resilience in choppy markets by filtering for 72 resilient stocks with low risk scores that pair steadier risk scores with dependable business profiles.
• Zero in on financial strength by running a solid balance sheet and fundamentals stocks screener (44 results) that highlights companies combining robust balance sheets with underlying fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.